Company Filing History:
Years Active: 2010
Title: Edgar S Diaz-Cruz: Innovator in Aromatase Modulation
Introduction
Edgar S Diaz-Cruz is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of selective aromatase modulators.
Latest Patents
Diaz-Cruz holds a patent for "Sulfonanilide analogs as selective aromatase modulators (SAMs)." This patent describes compounds and methods that suppress aromatase activity expression in cancer cells. The compounds are characterized by a specific formula, where R can be various chemical groups such as alkyl, cycloalkyl, haloalkyl, aryl, and others. The invention also includes small molecule selective aromatase inhibitors with a molecular weight of less than 500 g/mol, and methods for administering these inhibitors to treat conditions like breast cancer.
Career Highlights
Edgar S Diaz-Cruz is affiliated with The Ohio State University, where he continues to advance his research in the field of cancer therapeutics. His work focuses on developing effective treatments that target aromatase activity, which is crucial in the progression of certain cancers.
Collaborations
Diaz-Cruz has collaborated with esteemed colleagues such as Robert Brueggemeier and Bin Su. These partnerships have enhanced the scope and impact of his research, contributing to advancements in cancer treatment methodologies.
Conclusion
Edgar S Diaz-Cruz is a pioneering inventor whose work in aromatase modulation holds promise for improving cancer treatment options. His innovative approaches and collaborations continue to make a significant impact in the field of oncology.